Sandoz Group AG (Sandoz Group AG) EV-to-EBIT : (As of May. 12, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sandoz Group AG's Enterprise Value is $18,891 Mil. Sandoz Group AG does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Sandoz Group AG's EV-to-EBIT at this moment.

The historical rank and industry rank for Sandoz Group AG's EV-to-EBIT or its related term are showing as below:

SDZNY' s EV-to-EBIT Range Over the Past 10 Years
Min: -603572.4 Med: 0 Max: 59.61
Current: 59.61

During the past 2 years, the highest EV-to-EBIT of Sandoz Group AG was 59.61. The lowest was -603572.40. And the median was 0.00.

SDZNY's EV-to-EBIT is ranked worse than
88.19% of 669 companies
in the Drug Manufacturers industry
Industry Median: 17.95 vs SDZNY: 59.61

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Sandoz Group AG's Enterprise Value for the quarter that ended in Dec. 2023 was $17,215 Mil. Sandoz Group AG does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Sandoz Group AG's Earnings Yield (Joel Greenblatt) % at this moment.

Sandoz Group AG EV-to-EBIT Historical Data

The historical data trend for Sandoz Group AG's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG EV-to-EBIT Chart

Sandoz Group AG Annual Data

Trend

Dec22

Dec23

EV-to-EBIT

51.85

Sandoz Group AG Quarterly Data
	Dec22	Dec23
EV-to-EBIT	-	-

Competitive Comparison of Sandoz Group AG's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sandoz Group AG's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's EV-to-EBIT falls into.

Sandoz Group AG EV-to-EBIT Calculation

Sandoz Group AG's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	18890.662	/
	=

Sandoz Group AG (OTCPK:SDZNY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sandoz Group AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=		/	17215.02729
	=	%

Sandoz Group AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG (Sandoz Group AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

SDZXF:USA SDZz:UK D8Y0:Germany SDZ:Switzerland

Address

Forum 1, Novartis Campus, Basel, CHE, CH-4056

Website

https://www.sandoz.com

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024